Infliximab Therapy Could Decrease the Risk of the Development of Thyroid Disorders in Pediatric Patients With Crohn's Disease

by Aleksandra Furtak, Anna Maria Wedrychowicz, Malgorzata Sladek, Andrzej Wedrychowicz, Krzysztof Fyderek, Jerzy Starzyk
Published 2020-09-01

Diagnostic Value of Fecal Calprotectin (S100 A8/A9) Test in Children with Chronic Abdominal Pain

by Stanisław Pieczarkowski, Kinga Kowalska-Duplaga, Przemko Kwinta, Przemysław Tomasik, Andrzej Wędrychowicz, Krzysztof Fyderek
Published 2016-01-01

Gastric Lipase Secretion in Children with Gastritis

by Krystyna Sztefko, Krzysztof Fyderek, Andrzej Zając, Andrzej Wędrychowicz, Iwona Rogatko, Przemyslaw J. Tomasik
Published 2013-07-01

Dependence of Colonization of the Large Intestine by Candida on the Treatment of Crohn’s Disease

by KINGA KOWALSKA-DUPLAGA, AGNIESZKA KRAWCZYK, AGNIESZKA SROKA-OLEKSIAK, DOMINIKA SALAMON, ANDRZEJ WĘDRYCHOWICZ, KRZYSZTOF FYDEREK, TOMASZ GOSIEWSKI
Published 2019-03-01

Changes in the Intestinal Microbiota Are Seen Following Treatment with Infliximab in Children with Crohn’s Disease

by Kinga Kowalska-Duplaga, Przemysław Kapusta, Tomasz Gosiewski, Agnieszka Sroka-Oleksiak, Agnieszka H. Ludwig-Słomczyńska, Paweł P. Wołkow, Krzysztof Fyderek
Published 2020-03-01

The Influence of Ghrelin on the Development of Dextran Sodium Sulfate-Induced Colitis in Rats

by Aleksandra Matuszyk, Dagmara Ceranowicz, Zygmunt Warzecha, Piotr Ceranowicz, Krzysztof Fyderek, Krystyna Gałązka, Jakub Cieszkowski, Joanna Bonior, Jolanta Jaworek, Małgorzata Pihut, Artur Dembiński
Published 2015-01-01

Mn3+-saturated bovine lactoferrin as a new complex with potential prebiotic activities for dysbiosis treatment and prevention – On the synthesis, chemical characterization and orig...

by Klaudyna Śpiewak, Grzegorz Majka, Magdalena Pilarczyk- Żurek, Paweł M. Nowak, Michał Woźniakiewicz, Piotr Pietrzyk, Tomasz Korzeniak, Anna Stochel-Gaudyn, Krzysztof Fyderek, Magdalena Strus, Małgorzata Brindell
Published 2017-11-01

Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease

by Eva Gonçalves Serra, Tobias Schwerd, Loukas Moutsianas, Athena Cavounidis, Laura Fachal, Sumeet Pandey, Jochen Kammermeier, Nicholas M. Croft, Carsten Posovszky, Astor Rodrigues, Richard K. Russell, Farah Barakat, Marcus K. H. Auth, Robert Heuschkel, Matthias Zilbauer, Krzysztof Fyderek, Christian Braegger, Simon P. Travis, Jack Satsangi, Miles Parkes, Nikhil Thapar, Helen Ferry, Julie C. Matte, Kimberly C. Gilmour, Andrzej Wedrychowicz, Peter Sullivan, Carmel Moore, Jennifer Sambrook, Willem Ouwehand, David Roberts, John Danesh, Toni A. Baeumler, Tudor A. Fulga, Mohammad Karaminejadranjbar, Ahmed Ahmed, Rachel Wilson, Jeffrey C. Barrett, Abdul Elkadri, Anne M. Griffiths, COLORS in IBD group investigators, Oxford IBD cohort study investigators, INTERVAL Study, Swiss IBD cohort investigators, UK IBD Genetics Consortium, NIDDK IBD Genetics Consortium, Scott B. Snapper, Neil Shah, Aleixo M. Muise, David C. Wilson, Holm H. Uhlig, Carl A. Anderson
Published 2020-02-01